文献速递其他结缔组织病

干燥综合征的治疗:当前疗法与未来方向

Treatment of Sjögren's syndrome: current therapy and future directions.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

干燥综合征(SS)以严重疲劳、干燥、弥漫性疼痛、腺体肿胀及多种腺外表现为特征,既往临床试验多因入组患者无腺外表现、而疲劳干燥疼痛对研究药物反应不佳而失败。未来治疗需针对干眼干口症状、腺外疾病、疲劳及认知缺陷设计,创新方向包括与神经科学家及神经精神科医生合作或结合新的免疫靶向策略。

要点

  • 既往临床试验失败主因是入组患者无腺外表现且疲劳干燥疼痛对药物反应不佳。
  • 未来治疗应针对干眼干口、腺外疾病、疲劳及认知缺陷设计。
  • 创新方向包括与神经科学及神经精神科合作或结合新免疫靶向。

核心结论

  • 未来干燥综合征治疗需针对干眼干口症状、腺外疾病、疲劳及认知缺陷设计。
  • 创新方向涉及与神经科学家及神经精神科医生合作或结合新的免疫靶向策略可能更有前景。

研究设计与样本

  • 原文为综述,未报告系统检索范围。

主要发现

  • 干燥综合征通常表现为严重疲劳、干燥、弥漫性疼痛、腺体肿胀及多种腺外(系统性)表现。
  • 临床试验通常失败,因为绝大多数入组患者在入组时无腺外表现,但患有对研究药物无显著反应的疲劳、干燥和疼痛。
  • 已提出多种原发性干燥综合征(pSS)发病机制假说,包括先天性和适应性免疫紊乱以及与泪腺和分泌腺功能障碍相关的免疫紊乱与神经内分泌系统界面异常。

临床怎么用

  • 当前治疗选择不足且有限,未来需针对干眼干口症状、腺外疾病、疲劳及认知缺陷设计疗法。

局限性

  • 原文为综述,未报告系统检索范围及纳入研究的具体数量或质量评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SS is usually described as having severe fatigue, dryness, diffuse pain, glandular swelling, and various extraglandular (systemic) manifestations. Clinical trials have generally failed because the vast majority of enrolled patients had no extraglandular manifestations at the time of enrolment but suffered from fatigue, dryness and pain that did not significantly respond to the study medication. A number of hypotheses on the pathogenesis of pSS have been put forward, including disturbances of innate and adaptive immunity as well as abnormalities of the interface between immune disorders and the neuro-endocrine system related to lacrimal and secretory gland dysfunction. Thus, future therapies must be designed for improvement of the symptoms of dry eyes and dry mouth, extraglandular disease, and fatigue and cognitive deficits. Given the inadequacies and limitations of current treatment options, we suggest that innovative directions involving interactions with neuroscientists and neuropsychiatrists together or combined with new immune targeting may be hold promise for better treating pSS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fox RI, Fox CM, Gottenberg JE, et al. Treatment of Sjögren's syndrome: current therapy and future directions. Rheumatology (Oxford). 2021. PMID: 31034046. doi:10.1093/rheumatology/kez142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。